학술논문
FKBP12 contributes to [alpha]-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome
Document Type
Report
Author
Source
Proceedings of the National Academy of Sciences of the United States. December 26, 2017, Vol. 114 Issue 52, pE11313, 10 p.
Subject
Language
English
ISSN
0027-8424
Abstract
Calcineurin is an essential [Ca.sup.2+]-dependent phosphatase. Increased calcineurin activity is associated with [alpha]-synuclein ([alpha]-syn) toxicity, a protein implicated in Parkinson's Disease (PD) and other neurodegenerative diseases. Calcineurin can be inhibited with Tacrolimus through the recruitment and inhibition of the 12-kDa cis-trans proline isomerase FK506-binding protein (FKBP12). Whether calcineurin/FKBP12 represents a native physiologically relevant assembly that occurs in the absence of pharmacological perturbation has remained elusive. We leveraged [alpha]-syn as a model to interrogate whether FKBP12 plays a role in regulating calcineurin activity in the absence of Tacrolimus. We show that FKBP12 profoundly affects the calcineurin-dependent phosphoproteome, promoting the dephosphorylation of a subset of proteins that contributes to [alpha]-syn toxicity. Using a rat model of PD, partial elimination of the functional interaction between FKBP12 and calcineurin, with low doses of the Food and Drug Administration (FDA)-approved compound Tacrolimus, blocks calcineurin's activity toward those proteins and protects against the toxic hallmarks of [alpha]-syn pathology. Thus, FKBP12 can endogenously regulate calcineurin activity with therapeutic implications for the treatment of PD. calcineurin | FKBP12 | [alpha]-synuclein | Parkinson's Disease | Tacrolimus